Trends Parasitol. 2008 Aug;24(8):364-70. Epub 2008 Jul 1.

Flipping the paradigm on malaria transmission-blocking vaccines.

Source

Johns Hopkins Malaria Research Institute, Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA. rdinglas@jhsph.edu

Abstract

The idea of malaria transmission-blocking vaccines (TBVs) surfaced more than two decades ago. Since then, the research paradigm focused on developing TBVs that target surface antigens of parasite sexual stages. Only recently has an effort emerged that flipped this paradigm, targeting antigens of the parasite's obligate invertebrate vector, the Anopheles mosquito. Here, we review the current state of knowledge of mosquito-based TBVs and discuss the utility of this approach for future vaccine development.

PMID:: 18599352; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Malaria - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Monoclonal antibody MG96 completely blocks Plasmodium yoelii development in Anopheles stephensi. [Infect Immun. 2003]
Monoclonal antibody MG96 completely blocks Plasmodium yoelii development in Anopheles stephensi.
Dinglasan RR, Fields I, Shahabuddin M, Azad AF, Sacci JB Jr. Infect Immun. 2003 Dec; 71(12):6995-7001.
Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine. [Infect Immun. 2012]
Expression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.
Mathias DK, Plieskatt JL, Armistead JS, Bethony JM, Abdul-Majid KB, McMillan A, Angov E, Aryee MJ, Zhan B, Gillespie P, et al. Infect Immun. 2012 Apr; 80(4):1606-14. Epub 2012 Feb 6.
Review Current developments in malaria transmission-blocking vaccines. [Expert Opin Biol Ther. 2001]
Review Current developments in malaria transmission-blocking vaccines.
Stowers A, Carter R. Expert Opin Biol Ther. 2001 Jul; 1(4):619-28.
Peptide mimics as surrogate immunogens of mosquito midgut carbohydrate malaria transmission blocking targets. [Vaccine. 2005]
Peptide mimics as surrogate immunogens of mosquito midgut carbohydrate malaria transmission blocking targets.
Dinglasan RR, Porter-Kelley JM, Alam U, Azad AF. Vaccine. 2005 Apr 15; 23(21):2717-24.
Review A research agenda for malaria eradication: vaccines. [PLoS Med. 2011]
Review A research agenda for malaria eradication: vaccines.
malERA Consultative Group on Vaccines. PLoS Med. 2011 Jan 25; 8(1):e1000398. Epub 2011 Jan 25.

See reviews... See all...

Cited by 3 PubMed Central articles

Approaching the target: the path towards an effective malaria vaccine. [Mediterr J Hematol Infect Dis....]
Approaching the target: the path towards an effective malaria vaccine.
García-Basteiro AL, Bassat Q, Alonso PL. Mediterr J Hematol Infect Dis. 2012; 4(1):e2012015. Epub 2012 Mar 10.
Ookinete-interacting proteins on the microvillar surface are partitioned into detergent resistant membranes of Anopheles gambiae midguts. [J Proteome Res. 2011]
Ookinete-interacting proteins on the microvillar surface are partitioned into detergent resistant membranes of Anopheles gambiae midguts.
Parish LA, Colquhoun DR, Ubaida Mohien C, Lyashkov AE, Graham DR, Dinglasan RR. J Proteome Res. 2011 Nov 4; 10(11):5150-62. Epub 2011 Oct 17.
A role for heparan sulfate proteoglycans in Plasmodium falciparum sporozoite invasion of anopheline mosquito salivary glands. [Biochem J. 2011]
A role for heparan sulfate proteoglycans in Plasmodium falciparum sporozoite invasion of anopheline mosquito salivary glands.
Armistead JS, Wilson IB, van Kuppevelt TH, Dinglasan RR. Biochem J. 2011 Sep 15; 438(3):475-83.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Flipping the paradigm on malaria transmission-blocking vaccines.
Flipping the paradigm on malaria transmission-blocking vaccines.
Trends Parasitol. 2008 Aug ;24(8):364-70. Epub 2008 Jul 1 .

PubMed
The future of nicotine replacement.
The future of nicotine replacement.
Br J Addict. 1991 May ;86(5):653-8.

PubMed
Computerized physician order entry of medications and clinical decision support ...
Computerized physician order entry of medications and clinical decision support can improve problem list documentation compliance.
Int J Med Inform. 2010 May ;79(5):332-8. Epub 2008 Jul 2 .

PubMed
Generation of T follicular helper cells is mediated by interleukin-21 but indepe...
Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages.
Immunity. 2008 Jul 18 ;29(1):138-49. Epub 2008 Jul 3 .

PubMed
The signalling profile of recombinant human orexin-2 receptor.
The signalling profile of recombinant human orexin-2 receptor.
Cell Signal. 2008 Sep ;20(9):1651-61. Epub 2008 May 27 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: